CLOS
Compagnie Lombard Odier SCmA Portfolio holdings
AUM
$7.58B
This Quarter Return
+4.36%
1 Year Return
+23.11%
3 Year Return
+107.08%
5 Year Return
+161.87%
10 Year Return
+392.97%
AUM
$4.53B
AUM Growth
+$4.53B
(+17%)
Cap. Flow
+$524M
Cap. Flow
% of AUM
11.56%
Top 10 Holdings %
Top 10 Hldgs %
36.61%
Holding
723
New
123
Increased
148
Reduced
120
Closed
45
Top Buys
| 1 |
Adobe
ADBE
|
$36.9M |
| 2 |
Abbott
ABT
|
$24.2M |
| 3 |
Intellia Therapeutics
NTLA
|
$22.4M |
| 4 |
S&P Global
SPGI
|
$20.9M |
| 5 |
Tandem Diabetes Care
TNDM
|
$20.2M |
Top Sells
| 1 |
Walt Disney
DIS
|
$40.5M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$19.4M |
| 3 |
Apple
AAPL
|
$17.3M |
| 4 |
Futu Holdings
FUTU
|
$16.2M |
| 5 |
AbbVie
ABBV
|
$12.8M |
Sector Composition
| 1 | Healthcare | 22.18% |
| 2 | Communication Services | 16.63% |
| 3 | Technology | 16.07% |
| 4 | Financials | 13.49% |
| 5 | Consumer Discretionary | 12.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Allogene Therapeutics
ALLO
$249M
| $18.9M | 0.42% |
+536,738
| New | +$18.9M |
|
52
MetLife
MET
$53.6B
| $18.9M | 0.42% |
311,321
+23,085
| +8% | +$1.4M |
|
53
10x Genomics
TXG
$1.66B
| $17.9M | 0.39% |
+98,783
| New | +$17.9M |
|
54
NeoGenomics
NEO
$1.06B
| $17.4M | 0.38% |
+361,005
| New | +$17.4M |
|
55
Natera
NTRA
$23B
| $16.6M | 0.37% |
+163,278
| New | +$16.6M |
|
56
Apellis Pharmaceuticals
APLS
$3.51B
| $16.6M | 0.36% |
385,795
+382,795
| +12,760% | +$16.4M |
|
57
Freeport-McMoran
FCX
$66.3B
| $16.4M | 0.36% |
496,557
+219,360
| +79% | +$7.22M |
|
|
BHVN
58
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $16M | 0.35% |
+234,498
| New | +$16M |
|
|
TRHC
59
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $15.9M | 0.35% |
+344,334
| New | +$15.9M |
|
60
Booking.com
BKNG
$181B
| $15.8M | 0.35% |
6,794
+984
| +17% | +$2.29M |
|
|
INFO
61
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $15.5M | 0.34% |
159,843
-10,145
| -6% | -$982K |
|
|
IMGN
62
DELISTED
Immunogen Inc
IMGN
| $15M | 0.33% |
+1,849,772
| New | +$15M |
|
63
Nike
NKE
$110B
| $14.8M | 0.33% |
111,040
+13,766
| +14% | +$1.83M |
|
64
Neurocrine Biosciences
NBIX
$13.5B
| $14.6M | 0.32% |
+149,864
| New | +$14.6M |
|
|
GTHX
65
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $14.5M | 0.32% |
+601,591
| New | +$14.5M |
|
66
PayPal
PYPL
$66.5B
| $14M | 0.31% |
57,705
+13,788
| +31% | +$3.35M |
|
67
Johnson & Johnson
JNJ
$429B
| $13.6M | 0.3% |
82,710
+42,286
| +105% | +$6.95M |
|
|
DRNA
68
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $13.5M | 0.3% |
+526,058
| New | +$13.5M |
|
69
Twist Bioscience
TWST
$1.57B
| $13.2M | 0.29% |
+106,859
| New | +$13.2M |
|
70
Garmin
GRMN
$45.6B
| $13.2M | 0.29% |
100,300
-100
| -0.1% | -$13.2K |
|
71
McDonald's
MCD
$226B
| $13.1M | 0.29% |
58,531
-3,804
| -6% | -$853K |
|
72
Netflix
NFLX
$521B
| $13M | 0.29% |
24,938
+195
| +0.8% | +$102K |
|
|
MDRX
73
DELISTED
Veradigm Inc. Common Stock
MDRX
| $12.6M | 0.28% |
+839,521
| New | +$12.6M |
|
74
Medtronic
MDT
$118B
| $12.5M | 0.28% |
105,976
-6,699
| -6% | -$791K |
|
75
GoodRx Holdings
GDRX
$1.49B
| $12.3M | 0.27% |
+314,779
| New | +$12.3M |
|